Short-term Haematological and Biochemical Safety of Lu-177 DOTATATE Therapy

被引：0
|
作者：
Kauppila, E. [2 ]
Allen, R. [1 ]
Ifigeneia, K. [1 ]
Meades, R. [1 ]
Tan, T. [1 ]
Barwick, T. [1 ]
Soneji, N. [1 ]
Al-Nahhas, A. [1 ]
Win, Z. [1 ]
机构：
[1] Imperial Healthcare NHS Trust, London, England
[2] Univ Eastern Finlan, Kuopio, Finland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1033
引用
收藏
页码：S587 / S587
页数：1
相关论文
共 50 条
  • [1] Establishing a Lu-177 Dotatate Therapy Program
    Snyder, W.
    Harpool, K.
    Swanson, J. W.
    Schantz, P.
    Phan, A.
    Dick, J. S.
    Cavanaugh, S. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E499 - E500
  • [2] LU-177 DOTATATE THERAPY IN PATIENTS WITH NETS
    Hosking, E.
    McKay, E.
    Browne, E.
    Thomas, D.
    Liauw, W.
    Morris, D.
    Chu, F.
    Hayes, A.
    Butler, P.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 18 - 18
  • [3] The clinical efficacy and effectiveness of the Lu-177 DOTATATE therapy
    Acar, E.
    Durak, H.
    Kaya, G. Capa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S723 - S723
  • [4] Dosimetry using Lu-177 DOTATATE, Lu-177 HA-DOTATATE and Lu-177 DOTATOC: Comparative Results in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT)
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Shafaei, S.
    Kropf, S.
    Wester, H. J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S224 - S225
  • [5] Lu-177 Lutetium Dotatate Infusion Safety: Infiltration or Extravasation?
    Valencia, Brooke
    Peterson, Heather
    Huber, Casey
    Gansen, Denise
    Kendi, Ayse
    Paulsen, Andrew
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [6] DEAD TIME CORRECTION IN LU-177 DOTATATE THERAPY IMAGING
    Marciniak, C.
    Mckay, E.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 2 - 2
  • [7] Patient release after Lu-177 DOTATATE and Lu-177 PSMA 617 therapies
    Mair, C.
    Warwitz, B.
    Buxbaum, S.
    Virgolini, I. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S454 - S454
  • [8] Serial Dosimetry in Peptide Receptor Radionuclide Therapy using Lu-177 DOTATATE or Lu-177 DOTATOC in the same Patient
    Schuchardt, C.
    Kulkarni, H.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S139 - S139
  • [9] Lutetium Lu-177 Dotatate Flare Reaction
    Salner, Andrew L.
    Blankenship, Bette
    Dunnack, Hayley
    Niemann, Christopher
    Bertsch, Helaine
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (01)
  • [10] Lu-177 DOTATATE Retreatment: Efficacy and Toxicity
    Santillan, N.
    Ferreira, B.
    Gnanasegaran, G.
    Navalkisoor, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S757 - S757
12345